Biblio
Export 210 results:
Author Title Type [ Year
Filters: Keyword is Amyloid beta-Peptides [Clear All Filters]
“Acute Hyperglycemia Induced by Hyperglycemic Clamp Affects Plasma Amyloid-β in Type 2 Diabetes.”, J Alzheimers Dis, vol. 99, no. 3, pp. 1033-1046, 2024.
, “Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1199-1218, 2024.
, “Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years.”, J Alzheimers Dis, vol. 98, no. 1, pp. 151-161, 2024.
, “Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects.”, J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
, “Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 333-343, 2024.
, “Amyloid-Directed Antibodies: Past, Present, and Future.”, J Alzheimers Dis, vol. 101, no. s1, pp. S3-S22, 2024.
, “Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging.”, J Alzheimers Dis, vol. 100, no. s1, pp. S153-S164, 2024.
, “Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1235-1241, 2024.
, “Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.”, J Alzheimers Dis, vol. 100, no. 2, pp. 379-411, 2024.
, “The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
, “BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.”, J Alzheimers Dis, vol. 101, no. s1, pp. S53-S78, 2024.
, “Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
, “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
, “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
, “Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 100, no. 1, pp. 279-296, 2024.
, “High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?”, J Alzheimers Dis, vol. 97, no. 3, pp. 977-1005, 2024.
, “An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.”, J Alzheimers Dis, vol. 98, no. 2, pp. 601-618, 2024.
, “Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function.”, J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
, “Memory consolidation, temporal and parietal atrophy, and metabolism in amyloid-β positive and negative mild cognitive impairment.”, J Alzheimers Dis, vol. 102, no. 3, pp. 778-791, 2024.
, “Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 75-88, 2024.
, “The Neuro-Inflammatory Microenvironment: An Important Regulator of Stem Cell Survival in Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 741-754, 2024.
, “Primary cortical cell tri-culture to study effects of amyloid-β on microglia function and neuroinflammatory response.”, J Alzheimers Dis, vol. 102, no. 3, pp. 730-741, 2024.
, “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
,